Meteora Capital’s Orion Biotech Opportunities Corp. Class A Ordinary Share ORIA Stock Holding History

Meteora Capital’s Portfolio ORIA Stock Details ORIA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-366,183	Closed	-$3.75M	–	473
2023 Q1	$3.75M	Buy	+366,183	New	+$3.72M	0.44%	75

Meteora Capital's ORIA Position: Q2 2023 in Review

Meteora Capital sold out of Orion Biotech Opportunities Corp. Class A Ordinary Share (ORIA) in Q2 2023, closing a stake of 366,183 shares — an estimated $3.75M sold.

Meteora Capital first reported a position in ORIA in Q1 2023 and held it in 1 quarter. The position peaked at $3.75M in Q1 2023. 0 funds tracked by Wall St. Rank hold ORIA as of Q2 2023.

Meteora Capital reported no remaining Orion Biotech Opportunities Corp. Class A Ordinary Share position as of Q2 2023 after selling out during the quarter.
Meteora Capital sold 366,183 Orion Biotech Opportunities Corp. Class A Ordinary Share shares in Q2 2023, an estimated $3.75M.
Meteora Capital first reported a position in Orion Biotech Opportunities Corp. Class A Ordinary Share in Q1 2023 and held it in 1 quarter.
Meteora Capital's Orion Biotech Opportunities Corp. Class A Ordinary Share position peaked at $3.75M in Q1 2023.
0 funds tracked by Wall St. Rank held Orion Biotech Opportunities Corp. Class A Ordinary Share as of Q2 2023.

Based on Meteora Capital's 13F filing for Q2 2023, filed 14 Aug 2023.